Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE283.9900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots250.0000/ 1
- Ask / Lots288.8500/ 7
- Open / Previous Close278.4200 / 283.9900
- Day Range
- 52 Week Range
- Volume372,179
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 2067 | 278.65 |
| 09:36 ET | 425 | 276.415 |
| 09:38 ET | 616 | 276.13 |
| 09:39 ET | 1000 | 276.105 |
| 09:41 ET | 953 | 277.34 |
| 09:43 ET | 200 | 276.1 |
| 09:45 ET | 9541 | 280 |
| 09:48 ET | 9285 | 278.5 |
| 09:50 ET | 1600 | 278.21 |
| 09:52 ET | 970 | 279.0091 |
| 09:54 ET | 698 | 279.52 |
| 09:56 ET | 700 | 279.05 |
| 09:57 ET | 772 | 279.32 |
| 09:59 ET | 465 | 279.21 |
| 10:01 ET | 200 | 278.98 |
| 10:03 ET | 100 | 279.87 |
| 10:06 ET | 200 | 280.34 |
| 10:08 ET | 100 | 280.645 |
| 10:10 ET | 800 | 280.83 |
| 10:14 ET | 800 | 281.61 |
| 10:15 ET | 2081 | 281.8369 |
| 10:17 ET | 750 | 283.26 |
| 10:19 ET | 450 | 283.245 |
| 10:21 ET | 917 | 283.658 |
| 10:24 ET | 1940 | 285.7599 |
| 10:26 ET | 200 | 285.8 |
| 10:28 ET | 1600 | 283.6001 |
| 10:30 ET | 300 | 283.67 |
| 10:32 ET | 202 | 283.315 |
| 10:33 ET | 100 | 284.17 |
| 10:35 ET | 650 | 284.0818 |
| 10:37 ET | 1100 | 284.905 |
| 10:39 ET | 784 | 284.76 |
| 10:44 ET | 200 | 284.99 |
| 10:46 ET | 1100 | 285.55 |
| 10:48 ET | 392 | 286 |
| 10:50 ET | 500 | 285.735 |
| 10:51 ET | 100 | 285.7 |
| 10:53 ET | 2295 | 285.3 |
| 10:55 ET | 1680 | 284.79 |
| 10:57 ET | 100 | 283.76 |
| 11:00 ET | 800 | 284.64 |
| 11:02 ET | 300 | 284.63 |
| 11:04 ET | 300 | 283.935 |
| 11:09 ET | 546 | 284.25 |
| 11:11 ET | 204 | 284.25 |
| 11:13 ET | 100 | 284.705 |
| 11:18 ET | 3943 | 284.63 |
| 11:22 ET | 830 | 285 |
| 11:24 ET | 100 | 285.46 |
| 11:26 ET | 100 | 284.95 |
| 11:29 ET | 200 | 285.28 |
| 11:33 ET | 300 | 284.22 |
| 11:44 ET | 100 | 285.28 |
| 11:47 ET | 100 | 284.89 |
| 11:51 ET | 200 | 285.34 |
| 12:00 ET | 532 | 285.995 |
| 12:05 ET | 606 | 286.445 |
| 12:07 ET | 2110 | 285.83 |
| 12:09 ET | 1760 | 284.885 |
| 12:14 ET | 300 | 284.32 |
| 12:18 ET | 1201 | 283.93 |
| 12:20 ET | 1800 | 284.13 |
| 12:21 ET | 100 | 284.7 |
| 12:23 ET | 100 | 285.97 |
| 12:25 ET | 990 | 285.85 |
| 12:27 ET | 184 | 286.77 |
| 12:30 ET | 434 | 285.87 |
| 12:34 ET | 100 | 285.1 |
| 12:38 ET | 290 | 285.175 |
| 12:39 ET | 100 | 285.16 |
| 12:41 ET | 208 | 285.52 |
| 12:45 ET | 141 | 285.55 |
| 12:48 ET | 300 | 284.835 |
| 12:50 ET | 200 | 284.85 |
| 12:52 ET | 481 | 284.8 |
| 12:54 ET | 100 | 284.6 |
| 12:56 ET | 500 | 284.36 |
| 12:57 ET | 100 | 284.27 |
| 12:59 ET | 1541 | 284.31 |
| 01:01 ET | 381 | 284.5 |
| 01:03 ET | 100 | 284.505 |
| 01:06 ET | 1406 | 284.78 |
| 01:08 ET | 300 | 285.045 |
| 01:10 ET | 600 | 284.8 |
| 01:12 ET | 100 | 284.805 |
| 01:14 ET | 200 | 284.775 |
| 01:17 ET | 165 | 284.715 |
| 01:19 ET | 100 | 284.4 |
| 01:21 ET | 100 | 284.2 |
| 01:24 ET | 405 | 284.28 |
| 01:30 ET | 358 | 284.52 |
| 01:32 ET | 300 | 284.72 |
| 01:33 ET | 100 | 284.575 |
| 01:35 ET | 300 | 284.31 |
| 01:37 ET | 100 | 284.7 |
| 01:39 ET | 2400 | 286 |
| 01:44 ET | 700 | 285.8206 |
| 01:46 ET | 200 | 286.13 |
| 01:48 ET | 100 | 286.45 |
| 01:51 ET | 100 | 286.43 |
| 01:55 ET | 2699 | 286.11 |
| 01:57 ET | 567 | 286.015 |
| 02:02 ET | 100 | 285.485 |
| 02:04 ET | 100 | 285.25 |
| 02:08 ET | 1602 | 285.19 |
| 02:13 ET | 300 | 286.85 |
| 02:15 ET | 1159 | 286.87 |
| 02:18 ET | 1043 | 286.98 |
| 02:20 ET | 100 | 286.98 |
| 02:22 ET | 700 | 286.36 |
| 02:26 ET | 300 | 286.19 |
| 02:27 ET | 100 | 286.06 |
| 02:31 ET | 300 | 286.095 |
| 02:33 ET | 200 | 285.83 |
| 02:40 ET | 400 | 285.15 |
| 02:42 ET | 622 | 285.41 |
| 02:45 ET | 1552 | 286.2 |
| 02:47 ET | 200 | 286.01 |
| 02:49 ET | 200 | 285.94 |
| 02:51 ET | 200 | 285.97 |
| 02:58 ET | 1503 | 285.96 |
| 03:00 ET | 200 | 286.22 |
| 03:02 ET | 100 | 286.13 |
| 03:05 ET | 370 | 286.34 |
| 03:07 ET | 500 | 285.9 |
| 03:09 ET | 100 | 285.81 |
| 03:14 ET | 400 | 285.46 |
| 03:16 ET | 1557 | 285.765 |
| 03:21 ET | 4789 | 284.81 |
| 03:23 ET | 300 | 284.63 |
| 03:25 ET | 1653 | 283.86 |
| 03:27 ET | 700 | 282.23 |
| 03:30 ET | 1458 | 282.52 |
| 03:32 ET | 200 | 282.87 |
| 03:34 ET | 400 | 282.29 |
| 03:36 ET | 200 | 281.91 |
| 03:38 ET | 1022 | 282.755 |
| 03:39 ET | 520 | 282.3 |
| 03:41 ET | 2931 | 281.9 |
| 03:43 ET | 400 | 281.38 |
| 03:45 ET | 1000 | 280.49 |
| 03:48 ET | 500 | 280.98 |
| 03:50 ET | 1300 | 281.13 |
| 03:52 ET | 1204 | 282.04 |
| 03:54 ET | 2200 | 282.8605 |
| 03:56 ET | 2587 | 284.15 |
| 03:57 ET | 4149 | 284.06 |
| 03:59 ET | 3526 | 283.99 |
Jun 11, 2024
DJ Madrigal Pharmaceuticals Initiated at Outperform by Wolfe Research, from 2:48PM ET on Tuesday Jun 11, 2024 by Dow Jones
2:48PM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 6, 2024
Jun 5, 2024
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference, from 8:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
8:00AM ET on Wednesday Jun 05, 2024 by Dow JonesDJ S&P 500 Futures Rise In Premarket Trading; Hewlett Packard Ent, CrowdStrike Holdings Lead, from 7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
May 29, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 5.9B | -12.3x | --- |
Viking Therapeutics Inc | 5.8B | -56.0x | --- |
Cytokinetics Inc | 6.2B | -10.0x | --- |
Summit Therapeutics Inc | 5.6B | -48.3x | --- |
Revolution Medicines Inc | 6.3B | -10.2x | --- |
Nuvalent Inc | 5.1B | -33.5x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Chief Commercial Officer
- Carole Huntsman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 21.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.43 |
EPS | $-23.08 |
Book Value | $20.39 |
P/E Ratio | -12.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
